🤖 I’m a bot that provides automatic summaries for articles:
Click here to see the summary
Experts doubt the supply of the attention-deficit/hyperactivity disorder medication Adderall or other ADHD drugs will increase any time soon, with shortages potentially lasting through the end of the year.
Dr. Leila Javidi, a primary care doctor in Gahanna, Ohio has been fielding several hundred calls and messages each month from patients who say finding a stocked pharmacy becomes a time-consuming, frustrating quest.
The shortage began with Adderall last fall, but has since had a domino effect, with long- and short-acting versions of methylphenidate (Ritalin and Concerta), as well as Focalin, Vyvanse, and numerous generic equivalents of these drugs now in short supply, too.
Millions of children and adults in the United States are prescribed ADHD medications, which work by increasing dopamine levels in the brain to improve focus.
William Newman, an attorney who represents Ascent Pharmaceuticals with his partner Nick Oberheiden, said in an email that the company is still waiting on this year’s quota it requested from the DEA in 2022.
Even if telehealth changes do lower demand, Wiznitzer said, he wouldn’t be surprised if the ADHD medication shortage continues well into the fall, and potentially through the end of the year.
🤖 I’m a bot that provides automatic summaries for articles:
Click here to see the summary
Experts doubt the supply of the attention-deficit/hyperactivity disorder medication Adderall or other ADHD drugs will increase any time soon, with shortages potentially lasting through the end of the year.
Dr. Leila Javidi, a primary care doctor in Gahanna, Ohio has been fielding several hundred calls and messages each month from patients who say finding a stocked pharmacy becomes a time-consuming, frustrating quest.
The shortage began with Adderall last fall, but has since had a domino effect, with long- and short-acting versions of methylphenidate (Ritalin and Concerta), as well as Focalin, Vyvanse, and numerous generic equivalents of these drugs now in short supply, too.
Millions of children and adults in the United States are prescribed ADHD medications, which work by increasing dopamine levels in the brain to improve focus.
William Newman, an attorney who represents Ascent Pharmaceuticals with his partner Nick Oberheiden, said in an email that the company is still waiting on this year’s quota it requested from the DEA in 2022.
Even if telehealth changes do lower demand, Wiznitzer said, he wouldn’t be surprised if the ADHD medication shortage continues well into the fall, and potentially through the end of the year.
Saved 88% of original text.